Lista de obras - Janet A Dunn - Dominio Público Uruguay

195 Patient's experiences of a pre and post surgery rehabilitation programme for lung cancer (Rehabilitation Of lung Cancer (ROC) programme): a qualitative interview study

A 'new normal': Exploring the disruption of a poor prognostic cancer diagnosis using interviews and participant-produced photographs

artículo científico publicado en 2014

A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer

artículo científico publicado en 2012

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

artículo científico publicado en 2016

A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines

artículo científico publicado en 2017

A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities

artículo científico publicado en 2015

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

artículo científico publicado en 2020

A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer

artículo científico publicado en 1995

A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer

artículo científico publicado en 2006

A qualitative systematic review exploring lay understanding of cancer by adults without a cancer diagnosis

artículo científico publicado en 2014

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix

artículo científico publicado en 2000

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

artículo científico publicado en 2004

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

artículo científico publicado en 1998

A review of the issues and challenges involved in using participant-produced photographs in nursing research.

artículo científico publicado en 2015

Abstract P3-08-09: Is it me or is it hot in here? Hot flushes (or flashes): An unmet need. UK NCRI breast clinical studies group working party on symptom management (vasomotor)

article by A Morgan et al published 15 December 2013 in Cancer Research

Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer

Abstract PD2-02: NEO-EXCEL phase III neoadjuvant trial of pre-operative exemestane or letrozole +/- celecoxib in the treatment of ER positive postmenopausal early breast cancer

Common germline polymorphisms associated with breast cancer-specific survival

artículo científico publicado en 2015

Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone

artículo científico publicado en 2020

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3

artículo científico publicado en 2013

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

artículo científico

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

artículo científico publicado en 2006

Etoposide protein binding in cancer patients

artículo científico publicado en 1995

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.

artículo científico publicado en 2006

FKBPL: a marker of good prognosis in breast cancer

artículo científico publicado en 2015

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom

artículo científico publicado en 2012

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group

artículo científico publicado en 1998

Follow-up in early breast cancer--a surgical and radiological perceptive.

artículo científico publicado en 2014

Genome-wide association study of germline variants and breast cancer-specific mortality

artículo científico publicado en 2019

Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials

artículo científico publicado en 2016

Identification of novel genetic markers of breast cancer survival

artículo científico publicado en 2015

Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse

scientific article published on 01 April 1993

Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.

artículo científico publicado en 2005

LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection m

artículo científico publicado en 2013

Lesion size and histology of atypical cervical transformation zone

artículo científico publicado en 1991

Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer

artículo científico publicado en 2000

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

artículo científico publicado en 2017

MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma

artículo científico publicado en 1998

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform

artículo científico publicado en 2015

Management of advanced nodal disease in patients treated with primary chemoradiotherapy

artículo científico publicado en 2016

Management of hot flushes in UK breast cancer patients: clinician and patient perspectives.

artículo científico publicado en 2017

Multi-omic machine learning predictor of breast cancer therapy response

artículo científico publicado en 2021

National randomised controlled trial is needed

artículo científico publicado en 2008

Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

scientific article published on 01 June 1991

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?

artículo científico publicado en 2015

Nursing student attitudes to psychiatric nursing and psychiatric disorders in New Zealand

artículo científico publicado en 2005

OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism

artículo científico publicado en 2016

OP077

OP080

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer

artículo científico publicado en 2016

OT1-02-08: The PERSEPHONE Trial: Duration of Trastuzumab with Chemotherapy in Women with HER2 Positive Early Breast Cancer. Changing the Randomisation Point To Address Potential Barriers to Recruitment

Observer variability among colposcopists from the West Midlands region

artículo científico publicado en 1997

Options for early breast cancer follow-up in primary and secondary care - a systematic review

artículo científico publicado en 2012

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes

artículo científico publicado en 2015

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer ⬇️

artículo científico publicado en 2016

PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metasta ⬇️

artículo científico publicado en 2017

Pathogenesis of gall stones in Crohn's disease: an alternative explanation

artículo científico publicado en 1994

Phase III Randomised Study of Zoladex versus Stilboestrol in the Treatment of Advanced Prostate Cancer

artículo científico publicado en 1992

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

artículo científico publicado en 2009

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial

artículo científico publicado en 2010

Practicalities of using an adaptive design for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests.

artículo científico publicado en 2015

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also

artículo científico publicado en 2015

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).

artículo científico

Pregnancy outcome after large loop excision of the cervical transformation zone

artículo científico publicado en 1993

Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry

artículo científico publicado en 2016

Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial

Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial

artículo científico publicado en 2013

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group.

artículo científico publicado en 1999

Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery

artículo científico

Radiation Therapy Variation in the Randomized Phase 3 Positron Emission Tomography Neck Study

article by A. Hartley et al published October 2016 in International Journal of Radiation Oncology Biology Physics

Radical treatment of muscle-invasive bladder cancer—are options equal?

Rapid diagnostic service for patients with haematuria.

artículo científico publicado en 1994

Repeat testing for haematuria and underlying urological pathology

artículo científico publicado en 1994

Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel

artículo científico publicado en 2014

Resection-line involvement in gastric cancer: A continuing problem

artículo científico publicado en 1993

Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer

scientific article published on 01 July 2007

Screening for gastric cancer by Helicobacter pylori serology: a retrospective study.

artículo científico publicado en 1998

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial.

artículo científico publicado en 2012

Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V Trial

artículo científico publicado en 1993

Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

artículo científico publicado en 2020

Socio-economic deprivation and survival in bladder cancer

artículo científico publicado en 2004

Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival

article

Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer

artículo científico publicado en 1994

Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study

artículo científico publicado en 2020

The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study ⬇️

artículo científico publicado en 2016

The prognostic significance of intraperitoneal growth characteristics in epithelial ovarian carcinoma

article published in 1996

The quality of life of early breast cancer patients treated by two different radiotherapy regimens.

artículo científico publicado en 1993

The role of PET CT in the management of advanced nodal head neck cancer post chemoradiotherapy

The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up

artículo científico publicado en 1994

The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group ⬇️

artículo científico publicado el 1 de noviembre de 1992

The use of early decision modelling and value of information analysis in an adaptive trial design: results from the OPTIMA preliminary study.

artículo científico publicado en 2015

The value of source data verification in a cancer clinical trial

artículo científico publicado en 2012

Thoracoscore fails to predict complications following elective lung resection

artículo científico publicado en 2012

Trastuzumab-associated cardiac events in the Persephone trial

artículo científico publicado en 2016

Treatment Preferences of Urologists in Great Britain and Ireland in the Management of Prostate Cancer

scientific article published on 01 May 1993

UK ethnicity data collection for healthcare statistics: the South Asian perspective

artículo científico publicado en 2012

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

artículo científico publicado en 2016

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. ⬇️

artículo científico publicado en 2017

Lista de obras de Janet A Dunn

195 Patient's experiences of a pre and post surgery rehabilitation programme for lung cancer (Rehabilitation Of lung Cancer (ROC) programme): a qualitative interview study

A 'new normal': Exploring the disruption of a poor prognostic cancer diagnosis using interviews and participant-produced photographs

A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines

A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer

A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer

A qualitative systematic review exploring lay understanding of cancer by adults without a cancer diagnosis

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

A review of the issues and challenges involved in using participant-produced photographs in nursing research.

Abstract P3-08-09: Is it me or is it hot in here? Hot flushes (or flashes): An unmet need. UK NCRI breast clinical studies group working party on symptom management (vasomotor)

Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer

Abstract PD2-02: NEO-EXCEL phase III neoadjuvant trial of pre-operative exemestane or letrozole +/- celecoxib in the treatment of ER positive postmenopausal early breast cancer

Common germline polymorphisms associated with breast cancer-specific survival

Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

Etoposide protein binding in cancer patients

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.

FKBPL: a marker of good prognosis in breast cancer

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group

Follow-up in early breast cancer--a surgical and radiological perceptive.

Genome-wide association study of germline variants and breast cancer-specific mortality

Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials

Identification of novel genetic markers of breast cancer survival

Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse

Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.

LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection m

Lesion size and histology of atypical cervical transformation zone

Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform

Management of advanced nodal disease in patients treated with primary chemoradiotherapy

Management of hot flushes in UK breast cancer patients: clinician and patient perspectives.

Multi-omic machine learning predictor of breast cancer therapy response

National randomised controlled trial is needed

Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?

Nursing student attitudes to psychiatric nursing and psychiatric disorders in New Zealand

OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism

OP077

OP080

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer

OT1-02-08: The PERSEPHONE Trial: Duration of Trastuzumab with Chemotherapy in Women with HER2 Positive Early Breast Cancer. Changing the Randomisation Point To Address Potential Barriers to Recruitment

Observer variability among colposcopists from the West Midlands region

Options for early breast cancer follow-up in primary and secondary care - a systematic review

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer ⬇️

PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metasta ⬇️

Pathogenesis of gall stones in Crohn's disease: an alternative explanation

Phase III Randomised Study of Zoladex versus Stilboestrol in the Treatment of Advanced Prostate Cancer

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial

Practicalities of using an adaptive design for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests.

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).

Pregnancy outcome after large loop excision of the cervical transformation zone

Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry

Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial

Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group.

Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery

Radiation Therapy Variation in the Randomized Phase 3 Positron Emission Tomography Neck Study

Radical treatment of muscle-invasive bladder cancer—are options equal?

Rapid diagnostic service for patients with haematuria.

Repeat testing for haematuria and underlying urological pathology

Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel

Resection-line involvement in gastric cancer: A continuing problem

Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer

Screening for gastric cancer by Helicobacter pylori serology: a retrospective study.

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial.